F-1/A - Baird Medical Investment Holdings Ltd (0001982444) (Filer)

20-F - Baird Medical Investment Holdings Ltd (0001982444) (Filer)

NT 20-F - Baird Medical Investment Holdings Ltd (0001982444) (Filer)

6-K - Baird Medical Investment Holdings Ltd (0001982444) (Filer)

F-1/A - Baird Medical Investment Holdings Ltd (0001982444) (Filer)

S-8 - Baird Medical Investment Holdings Ltd (0001982444) (Filer)

F-1 - Baird Medical Investment Holdings Ltd (0001982444) (Filer)

6-K - Baird Medical Investment Holdings Ltd (0001982444) (Filer)

20FR12B - Baird Medical Investment Holdings Ltd (0001982444) (Filer)

NEW YORK, Oct. 23, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD), a global leader in minimally invasive Microwave Ablation (MWA) technology, today announced the successful completion of its first MWA procedure in Bangladesh. The landmark treatment was performed at USB Hospital in Uttara, Dhaka, marking a significant step forward in the availability of cutting-edge, non-surgical cancer therapies in the region. The procedure was led by Dr. Mofazzal Sharif Rasel, a distinguished interventional radiologist, and his expert medical team. The patient, a 65

In the news release, Baird Medical Fosters Advanced Physician Training at International Thyroid Microwave Ablation Workshop in Malaysia, issued 21-Oct-2025 by BDMD over PR Newswire, we are advised by the company that the second paragraph, second sentence, should read "Led by a distinguished faculty, Proctor Dr. Shuhang Xu, endocrinologist at Jiangsu Provincial Hospital, alongside HCTM's B&E Surgeons Dr. Adi Syazni and Prof. Shahrun Niza, the program featured a rigorous curriculum encompassing theoretical lectures, complex case discussions, and practical training sessions using both mannequins and live patient cases." rather than "...endocrinologist at Nanjing University of Traditional Chines

NEW YORK, Oct. 21, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD), a global leader in minimally invasive Microwave Ablation (MWA) technology, today announced its successful participation in the Thyroid Microwave Ablation Workshop held at the Hospital Canselor Tuanku Muhriz (HCTM) of The National University of Malaysia. The immersive two-day workshop, held from October 1–2, 2025, brought together leading surgeons and endocrinologists for intensive, hands-on training. Led by a distinguished faculty, Proctor Dr. Shuhang Xu, endocrinologist at Nanjing Un

NEW YORK, Oct. 20, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD), a global leader in minimally invasive Microwave Ablation (MWA) technology, today announced its participation in the 3rd International Workshop on Thermal Ablation of Thyroid Tumor and Hyperparathyroidism. The prestigious academic event was hosted by the China-Japan Friendship Hospital in Beijing, China, from October 17-18, 2025. Chaired by Prof. Ming'an Yu, a leading authority in interventional medicine, the workshop served as a vital platform for the world's foremost experts to share

NEW YORK, Oct. 16, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD) ("Baird Medical" or the "Company"), a global leader in minimally invasive Microwave Ablation (MWA) technology, announced its system was successfully used in two minimally invasive procedures at UCSF Health. Esteemed interventional radiologist Dr. Alexander Lam performed the procedures, treating large, symptomatic thyroid nodules that would typically require surgery. The cases involved two patients with benign nodules measuring 5.0 cm and 6.5 cm. The non-surgical ablations were complete

NEW YORK, Oct. 14, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD) ("BAIRD MEDICAL" or the "Company"), a global leader in minimally invasive Microwave Ablation (MWA) technology, highlighted the significant findings of a cost-utility analysis conducted by researchers at Johns Hopkins University. The study abstract, presented at the recent American Thyroid Association (ATA) Annual Meeting, concludes that management strategies incorporating transcutaneous thyroid nodule ablation (TNA) can lead to lower healthcare costs and improved patient quality of life.

NEW YORK, Oct. 9, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD) ("Baird Medical" or the "Company"), a global leader in minimally invasive Microwave Ablation (MWA) technology, has successfully concluded its participation in the American College of Surgeons (ACS) Clinical Congress 2025, held from October 5-7. The event served as a key platform for showcasing the Company's innovative technology to a global surgical audience. At its exhibit, Baird Medical's advanced MWA systems drew significant interest from surgeons across multiple specialties. The liv

NEW YORK, Oct. 6, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD) ("Baird Medical" or the "Company"), a global leader in minimally invasive Microwave Ablation (MWA) technology, is participating in the American College of Surgeons (ACS) Clinical Congress 2025 in Chicago, IL. The prestigious event is being held from October 5-7 and brings together tens of thousands of surgeons from around the world to explore the latest advancements in surgical care. The ACS, established in 1913, is the world's largest and most influential organization for surgeons, boa

NEW YORK, Oct. 1, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD) ("Baird Medical" or the "Company"), a global leader in minimally invasive Microwave Ablation (MWA) technology, highlighted its recent series of sponsored physician training programs hosted at premier U.S. academic medical centers. Over the past several months, these intensive, hands-on courses at Tulane University and Columbia University have advanced the clinical proficiency of physicians in the use of MWA for thyroid nodule treatment. These initiatives underscore Baird Medical's commi

NEW YORK, Sept. 29, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a global leader in minimally invasive Microwave Ablation (MWA) technology, announced its successful participation in the 2025 American Thyroid Association (ATA) Annual Meeting. The event drew significant engagement from a global audience of physicians and researchers, reinforcing the growing international interest in the Company's innovative solutions. The Company's exhibition booth served as a central hub for leading endocrinologists, surgeons, an

NEW YORK, Oct. 20, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ:BDMD), a global leader in minimally invasive Microwave Ablation (MWA) technology, today announced its participation in the 3rd International Workshop on Thermal Ablation of Thyroid Tumor and Hyperparathyroidism. The prestigious academic event was hosted by the China-Japan Friendship Hospital in Beijing, China, from October 17-18, 2025. Chaired by Prof. Ming'an Yu, a leading authority in interventional medicine, the workshop served as a vital platform for the world's foremost experts to share